Recent Press Releases

Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu

BEIJING, July 23, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers...

Sinovac Receives Tender to Supply Inactivated Hepatitis A Vaccine Healive in Beijing Under Expanded Immunization Program

BEIJING, July 21, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. SVA +1.76% , a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Health...

Genocea HSV-2 Immunotherapeutic GEN-003 Elicits Significant, Durable T Cell Responses in Vaccinated Subjects

Immunogenicity Data from Phase 1/2a Trial Highlighted at 39th Annual International Herpesvirus Workshop CAMBRIDGE, Mass., Jul 22, 2014 (BUSINESS WIRE) -- Genocea Biosciences, Inc. GNCA -12.37% , a...

Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States

- Largest U.S. influenza vaccine supplier, providing broad product portfolio, will distribute at least 65 million doses to help protect people across multiple age groups against the virus this season...

( GOVX GOVX ) GeoVax Awarded Small Business Innovative Research (SBIR) Grant from National Institutes of Health

Atlanta, GA / ACCESSWIRE / July 16, 2014 / GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing vaccines to prevent and treat HIV/AIDS, announced today it has received a Notice of...

Donna Ambrosino Joins ClearPath Vaccines Company as Chief Medical Officer

Brings More than 25 Years of Biologics and Drug Development Experience to New Position ROCKVILLE, Md., July 15, 2014 /PRNewswire/ -- ClearPath Development Company (ClearPath) announced today that...

Hemispherx Biopharma and Bioclones, a Leading South African Biotechnology Company, Join Forces on Novel Therapeutic Cancer Vaccine

Hemispherx Biopharma and Bioclones, a Leading South African Biotechnology Company, Join Forces on Novel Therapeutic Cancer Vaccine Builds on Recently Issued Patent Estates of Both Companies and...

The Lancet: Extra dose of inactivated polio vaccine boosts immunity in children and could speed up global eradication efforts

Giving children under 5 years old an extra dose of inactivated polio vaccine (IPV) helps to boost their immunity to the poliovirus and should be added to vaccination programmes in polio-endemic...

Microbix Sues Novartis for Infringement of its VIRUSMAX® Patent In Europe

TORONTO July 10, 2014 — Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, announced today it has commenced a new patent litigation in the Court of...

Novartis maintained strong innovation momentum in second quarter, while reconfirming full year outlook

Net sales grew 2%[1] in Q2, with core operating leverage across Q2 and H1 Net sales of USD 14.6 billion grew 2% (+2% cc[2]) in Q2; USD 28.7 billion (+2%, +2% cc) in H1 Strong operating income...

GSK begins shipping 2014-15 U.S. flu vaccines

Expected 28 - 33 million doses of four-strain and three-strain flu shots will help meet U.S. public health needs GSK [LSE/NYSE: GSK] announced today it has begun shipping FLUARIX® QUADRIVALENT...

First Ever Dengue Vaccine Candidate To Show Efficacy Against Dengue Fever and Dengue Haemorrhagic Fever in Asia

First Ever Dengue Vaccine Candidate To Show Efficacy Against Dengue Fever and Dengue Haemorrhagic Fever in Asia - 88.5% reduction of Dengue Haemorrhagic Fever shown in detailed analyses of...

Protein Sciences Receives Approval from FDA for 2014/15 Formulation of Flublok® Influenza Vaccine

MERIDEN, Conn., July 8, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the FDA has approved the Company's strain change amendment for its seasonal influenza vaccine,...

MabVax Therapeutics And Telik Announce Closing of Merger

SAN DIEGO, July 9, 2014 /PRNewswire/ -- MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, and Telik, Inc. (Nasdaq: TELK), a publicly-traded clinical stage oncology drug...

The Cancer Immunotherapy Market Will Increase to Nearly $9 Billion Across the World's Major Pharmaceutical Markets In 2022

Immune Checkpoint Inhibitors Will Hold an Impressive 85 Percent Market Share, According to Findings from Decision Resources Group June 30, 2014 - Burlington, Mass. – Decision Resources Group...

Novartis begins shipping flu vaccines ahead of crucial season

CAMBRIDGE, Mass., July 2, 2014 /PRNewswire/ -- Novartis announced today that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2014-2015 season. Novartis...

Specialty Vaccine Company PaxVax Announces Positive Efficacy Results for Phase 3 Cholera Challenge Study

New Efficacy Data Adds to Successful Phase 3 Clinical Trial Program Results for Single-Dose Oral Cholera Vaccine for Travelers' Market and People in the Developing World REDWOOD CITY, Calif.,...

Agenus Brain Cancer Vaccine Shows Extended Survival in Phase 2 Final Data Analysis

LEXINGTON, Mass.--(BUSINESS WIRE)--July 01, 2014-- Agenus Inc. (NASDAQ: AGEN), announced final results from a single-arm, multi-institutional, open-label, Phase 2 study showing that patients with...

Sinovac Announces Favorable Reduction in Value Added Tax Rate

BEIJING, June 25, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. SVA +5.25% , a leading provider of biopharmaceutical products in China, today announced that the value added tax (or "VAT")...

GlycoVaxyn announces the initiation of a Phase I clinical trial in collaboration with Janssen for a vaccine against Extra-intestinal pathogenic Escherichia coli causing urinary tract infection

ZURICH-SCHLIEREN, Switzerland, Jul 1, 2014 (Canada NewsWire via COMTEX) -- GlycoVaxyn AG, a leader in the development of innovative conjugate vaccines, today announced the initiation of a Phase 1...